The five-year incidence of blindness after introducing a screening programme for early detection of treatable diabetic retinopathy
(1993) In Diabetic Medicine 10(6). p.555-559- Abstract
- The incidence of moderate visual impairment and blindness due to diabetic retinopathy was studied 5 years after introducing a screening system for early detection of treatable retinopathy. Photocoagulation was performed in patients with clinically significant macular oedema, severe preproliferative, and proliferative retinopathy. Eighty-eight percent of 470 Type 1 and 88% of 388 Type 2 diabetic patients were still available for follow-up. In the Type 1 group, the five-year incidence of blindness and moderate visual impairment were 0.5% and 1.2%, respectively. Corresponding figures for the Type 2 diabetic patients were 0.6% and 1.7%, respectively. The majority of patients with loss of vision had severe retinopathy at baseline. Among those... (More)
- The incidence of moderate visual impairment and blindness due to diabetic retinopathy was studied 5 years after introducing a screening system for early detection of treatable retinopathy. Photocoagulation was performed in patients with clinically significant macular oedema, severe preproliferative, and proliferative retinopathy. Eighty-eight percent of 470 Type 1 and 88% of 388 Type 2 diabetic patients were still available for follow-up. In the Type 1 group, the five-year incidence of blindness and moderate visual impairment were 0.5% and 1.2%, respectively. Corresponding figures for the Type 2 diabetic patients were 0.6% and 1.7%, respectively. The majority of patients with loss of vision had severe retinopathy at baseline. Among those who entered the screening programme with no or mild retinopathy, loss of vision occurred in only one of the Type 1 and four of the Type 2 diabetic patients. It is concluded that the risk for visual impairment and blindness due to diabetes can be substantially reduced by using programmes for early detection of and effective treatment of diabetic retinopathy. (Less)
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/1107197
- author
- Agardh, Elisabet LU ; Agardh, Carl-David LU and Hansson-Lundblad, C
- organization
- publishing date
- 1993
- type
- Contribution to journal
- publication status
- published
- subject
- in
- Diabetic Medicine
- volume
- 10
- issue
- 6
- pages
- 555 - 559
- publisher
- Wiley-Blackwell
- external identifiers
-
- pmid:8365093
- scopus:0027207733
- ISSN
- 1464-5491
- language
- English
- LU publication?
- yes
- additional info
- The information about affiliations in this record was updated in December 2015. The record was previously connected to the following departments: Unit on Vascular Diabetic Complications (013241510)
- id
- 0967c516-b36f-4a87-96b0-6e2cf39b157b (old id 1107197)
- date added to LUP
- 2016-04-01 16:57:20
- date last changed
- 2021-04-25 04:13:04
@article{0967c516-b36f-4a87-96b0-6e2cf39b157b,
abstract = {{The incidence of moderate visual impairment and blindness due to diabetic retinopathy was studied 5 years after introducing a screening system for early detection of treatable retinopathy. Photocoagulation was performed in patients with clinically significant macular oedema, severe preproliferative, and proliferative retinopathy. Eighty-eight percent of 470 Type 1 and 88% of 388 Type 2 diabetic patients were still available for follow-up. In the Type 1 group, the five-year incidence of blindness and moderate visual impairment were 0.5% and 1.2%, respectively. Corresponding figures for the Type 2 diabetic patients were 0.6% and 1.7%, respectively. The majority of patients with loss of vision had severe retinopathy at baseline. Among those who entered the screening programme with no or mild retinopathy, loss of vision occurred in only one of the Type 1 and four of the Type 2 diabetic patients. It is concluded that the risk for visual impairment and blindness due to diabetes can be substantially reduced by using programmes for early detection of and effective treatment of diabetic retinopathy.}},
author = {{Agardh, Elisabet and Agardh, Carl-David and Hansson-Lundblad, C}},
issn = {{1464-5491}},
language = {{eng}},
number = {{6}},
pages = {{555--559}},
publisher = {{Wiley-Blackwell}},
series = {{Diabetic Medicine}},
title = {{The five-year incidence of blindness after introducing a screening programme for early detection of treatable diabetic retinopathy}},
volume = {{10}},
year = {{1993}},
}